DGAP-News: AiCuris Anti-infective Cures GmbH / Key word(s): Miscellaneous
AiCuris changes its legal form: AiCuris Anti-infective Cures GmbH becomes AiCuris AG
01.02.2021 / 09:00
AiCuris changes its legal form:
AiCuris Anti-infective Cures GmbH becomes AiCuris AG
Transition will support the Company in exploring additional opportunities for future growth
AiCuris shareholders elect Helga Rübsamen-Schaeff, Sean Marett and Helmut Jeggle to the inital Supervisory Board
Supervisory board confirms Holger Zimmermann as CEO and Holger Schmoll as CFO
WUPPERTAL, Germany, February 01, 2021 - AiCuris Anti-infective Cures GmbH ( AiCuris or the Company ), a leading company in the discovery and development of drugs against infectious diseases, today announced that the Company s shareholder resolved to change the legal form from the German GmbH (limited-liability company) to a stock corporation (Aktiengesellschaft or AG ).
Press release content from Accesswire. The AP news staff was not involved in its creation.
AiCuris Changes its Legal Form: AiCuris Anti-infective Cures GmbH becomes AiCuris AG
February 1, 2021 GMT
AiCuris shareholders elect Helga Rübsamen-Schaeff, Sean Marett and Helmut Jeggle to the inital Supervisory Board
Supervisory board confirms Holger Zimmermann as CEO and Holger Schmoll as CFO
WUPPERTAL, GERMANY / ACCESSWIRE / February 01, 2021 / AiCuris Anti-infective Cures GmbH (“AiCuris” or “the Company”), a leading company in the discovery and development of drugs against infectious diseases, today announced that the Company’s shareholder resolved to change the legal form from the German “GmbH” (limited-liability company) to a stock corporation (Aktiengesellschaft or “AG”).